319472-55-4 Usage
Properties
1. Chemical compound
2. Boronic acid group
3. Phenyl ring
4. Two methoxy groups
5. Additional methoxymethoxy group
6. Used in organic synthesis and pharmaceutical research
7. Potential applications in drug development
8. Valuable tool for the development of new drugs and materials
9. Used in production of various organic compounds
Specific content
1. Boronic acid group attached to a phenyl ring
2. Two methoxy groups attached to the phenyl ring
3. Additional methoxymethoxy group attached to the phenyl ring
4. Commonly used in organic synthesis and pharmaceutical research
5. Studied for potential applications in drug development, particularly in cancer research
6. Used in the production of various organic compounds including pharmaceuticals, agrochemicals, and fine chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 319472-55-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,9,4,7 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 319472-55:
(8*3)+(7*1)+(6*9)+(5*4)+(4*7)+(3*2)+(2*5)+(1*5)=154
154 % 10 = 4
So 319472-55-4 is a valid CAS Registry Number.
319472-55-4Relevant articles and documents
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
-
, (2008/06/13)
Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
